Combined formulation of Doxorubicin-Arg-Gly-Asp (RGD) and modified PEGylated PLGA-encapsulated nanocarrier improves anti-tumor activity.
Resource URI: https://dblp.l3s.de/d2r/resource/publications/conf/bibm/MoffattCB12
Home
|
Example Publications
Property
Value
dcterms:
bibliographicCitation
<
http://dblp.uni-trier.de/rec/bibtex/conf/bibm/MoffattCB12
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Richard_Cristiano
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Rose_Boyle
>
dc:
creator
<
https://dblp.l3s.de/d2r/resource/authors/Stanley_Moffatt
>
foaf:
homepage
<
http://dx.doi.org/doi.org%2F10.1109%2FBIBMW.2012.6470261
>
foaf:
homepage
<
https://doi.org/10.1109/BIBMW.2012.6470261
>
dc:
identifier
DBLP conf/bibm/MoffattCB12
(xsd:string)
dc:
identifier
DOI doi.org%2F10.1109%2FBIBMW.2012.6470261
(xsd:string)
dcterms:
issued
2012
(xsd:gYear)
rdfs:
label
Combined formulation of Doxorubicin-Arg-Gly-Asp (RGD) and modified PEGylated PLGA-encapsulated nanocarrier improves anti-tumor activity.
(xsd:string)
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Richard_Cristiano
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Rose_Boyle
>
foaf:
maker
<
https://dblp.l3s.de/d2r/resource/authors/Stanley_Moffatt
>
swrc:
pages
903-909
(xsd:string)
dcterms:
partOf
<
https://dblp.l3s.de/d2r/resource/publications/conf/bibm/2012w
>
owl:
sameAs
<
http://bibsonomy.org/uri/bibtexkey/conf/bibm/MoffattCB12/dblp
>
owl:
sameAs
<
http://dblp.rkbexplorer.com/id/conf/bibm/MoffattCB12
>
rdfs:
seeAlso
<
http://dblp.uni-trier.de/db/conf/bibm/bibmw2012.html#MoffattCB12
>
rdfs:
seeAlso
<
https://doi.org/10.1109/BIBMW.2012.6470261
>
swrc:
series
<
https://dblp.l3s.de/d2r/resource/conferences/bibm
>
dc:
title
Combined formulation of Doxorubicin-Arg-Gly-Asp (RGD) and modified PEGylated PLGA-encapsulated nanocarrier improves anti-tumor activity.
(xsd:string)
dc:
type
<
http://purl.org/dc/dcmitype/Text
>
rdf:
type
swrc:InProceedings
rdf:
type
foaf:Document